4530.T

Hisamitsu Pharmaceutical Co., Inc. [4530.T] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

4530.T Stock Summary

Top 10 Correlated Stocks

4530.T

In the News

4530.T Financial details

Company Rating
-
Market Cap
296.08B
Income
13.97B
Revenue
141.71B
Book val./share
-
Cash/share
-
Dividend
42.75
Dividend %
0.95%
Employees
2.77K
Optionable
No
Shortable
Yes
Earnings
11 Jul 2024
P/E
25.66
Forward P/E
-
PEG
11.23
P/S
2.57
P/B
1.28
P/C
-
P/FCF
-
Quick Ratio
3.38
Current Ratio
3.97
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
181.82
EPS next Y
-
EPS next Q
-
EPS this Y
22.72%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.41%
Revenue last 5Y
0.1%
Revenue Q/Q
8.45%
EPS Q/Q
-48.54%
-
-
-
-
SMA20
-3.21%
SMA50
-6.73%
SMA100
-2.53%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
5%
ROC
0.05%
Gross Margin
57%
Oper. Margin
11%
Profit Margin
10%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3541.0-5497.0
52W High
-27.16%
52W Low
+13.08%
RSI
44
Rel Volume
1.2
Avg Volume
164.67K
Volume
198.2K
Perf Week
-0.25%
Perf Month
-5.14%
Perf Quarter
-7.19%
Perf Half Y
-9.76%
-
-
-
-
Beta
0.404
-
-
Volatility
36.4%, 81.44%
Prev Close
0%
Price
4004
Change
-0.07%

4530.T Financial Performance

4530.T Dividend History

4530.T Frequently Asked Questions

What is Hisamitsu Pharmaceutical Co., Inc. stock symbol ?

Hisamitsu Pharmaceutical Co., Inc. is a JP stock and trading under the symbol 4530.T

What is Hisamitsu Pharmaceutical Co., Inc. stock quote today ?

Hisamitsu Pharmaceutical Co., Inc. stock price is $4004 today.

Is Hisamitsu Pharmaceutical Co., Inc. stock public?

Yes, Hisamitsu Pharmaceutical Co., Inc. is a publicly traded company.

Something similar

Top by Market Cap
LLY.SW
GOOG
TSLA
ABEA.DE
CMC.DE
Same Sector
VERU
EGTX.ST
BSX
CTX.WA
SMSA
Top Correlated Stocks
8617.T
7803.T
2395.T
4337.T
4475.T
Similar Market Cap
1332.T
8114.T
012630.KS
001790.KS
BABA

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 164.67K
  • Market Capitalization 296.08B
  • Employee 2.77K
  • CEO Mr. Kazuhide Nakatomi
  • Headquarters Tosu,JP
  • IPO Date 2001-01-01
  • Website https://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.